analysis,Reporting < 2 yrs,Summary results < 1 yr,Any results reporting
Main analysis,"1098/2113, 52% (95%CI 49.8-54.1%)","42/2113, 2% (95%CI 1.5-2.7%)","1642/2113, 77.7% (95%CI 75.9-79.4%)"
Only RCTs,"792/1516, 52.2% (95%CI 49.7-54.7%)","27/1516, 1.8% (95%CI 1.2-2.6%)","1176/1516, 77.6% (95%CI 75.4-79.6%)"
Restricted to EUCTR,"262/432, 60.6% (95%CI 56-65.1%)","29/432, 6.7% (95%CI 4.7-9.5%)","377/432, 87.3% (95%CI 83.8-90.1%)"
Restricted to ClinicalTrials.gov,"1042/2008, 51.9% (95%CI 49.7-54.1%)","34/2008, 1.7% (95%CI 1.2-2.4%)","1553/2008, 77.3% (95%CI 75.5-79.1%)"
Exclude trials with unknown status,"973/1825, 53.3% (95%CI 51-55.6%)","42/1825, 2.3% (95%CI 1.7-3.1%)","1482/1825, 81.2% (95%CI 79.3-82.9%)"
Only completed trials,"932/1675, 55.6% (95%CI 53.3-58%)","37/1675, 2.2% (95%CI 1.6-3%)","1414/1675, 84.4% (95%CI 82.6-86.1%)"
